Danaher (NYSE:DHR) Director Sells $586,324.68 in Stock

Key Points

• Danaher Corporation Director Teri List sold $586,324.68 worth of stock, reducing their ownership by 11.81% to a total of 20,751 shares.
• The company's shares traded down to $207.89, with a 12-month range between $171.00 and $279.90.
• Analysts have set a consensus target price of $247.61 for Danaher, with a majority rating it as a "Moderate Buy".

Danaher Corporation (NYSE:DHR - Get Free Report) Director Teri List sold 2,778 shares of the firm's stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares in the company, valued at $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Danaher Price Performance

Shares of NYSE:DHR traded down $3.9090 during trading on Monday, reaching $207.8910. The company had a trading volume of 1,985,630 shares, compared to its average volume of 4,209,324. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $279.90. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $148.86 billion, a P/E ratio of 44.23, a price-to-earnings-growth ratio of 2.96 and a beta of 0.73. The company has a fifty day moving average of $200.67 and a two-hundred day moving average of $199.37.

Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.16. The company had revenue of $5.94 billion during the quarter, compared to analyst estimates of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm's quarterly revenue was up 3.4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities research analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current year.

Analysts Set New Price Targets

A number of analysts recently weighed in on the company. Guggenheim restated a "buy" rating and issued a $250.00 target price on shares of Danaher in a research report on Wednesday, July 23rd. Robert W. Baird upped their price objective on shares of Danaher from $225.00 to $226.00 and gave the company an "outperform" rating in a research note on Friday, July 18th. Evercore ISI decreased their target price on shares of Danaher from $230.00 to $226.00 and set an "outperform" rating on the stock in a research report on Tuesday, July 8th. Wells Fargo & Company lowered their price target on shares of Danaher from $210.00 to $205.00 and set an "equal weight" rating for the company in a research note on Wednesday, July 23rd. Finally, Deutsche Bank Aktiengesellschaft reduced their price objective on Danaher from $240.00 to $235.00 in a research note on Thursday, June 5th. Seventeen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, Danaher currently has a consensus rating of "Moderate Buy" and an average price target of $247.61.

Institutional Trading of Danaher

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. White Pine Capital LLC boosted its stake in shares of Danaher by 1.4% during the 2nd quarter. White Pine Capital LLC now owns 3,494 shares of the conglomerate's stock valued at $690,000 after purchasing an additional 49 shares in the last quarter. Coastal Bridge Advisors LLC boosted its position in Danaher by 4.8% during the 4th quarter. Coastal Bridge Advisors LLC now owns 1,099 shares of the conglomerate's stock valued at $252,000 after acquiring an additional 50 shares in the last quarter. Boyd Watterson Asset Management LLC OH grew its holdings in shares of Danaher by 2.1% during the 2nd quarter. Boyd Watterson Asset Management LLC OH now owns 2,524 shares of the conglomerate's stock worth $499,000 after acquiring an additional 51 shares during the period. Hills Bank & Trust Co grew its holdings in shares of Danaher by 0.3% during the 1st quarter. Hills Bank & Trust Co now owns 18,015 shares of the conglomerate's stock worth $3,693,000 after acquiring an additional 53 shares during the period. Finally, Worth Financial Advisory Group LLC lifted its stake in shares of Danaher by 4.6% in the 2nd quarter. Worth Financial Advisory Group LLC now owns 1,195 shares of the conglomerate's stock valued at $236,000 after purchasing an additional 53 shares during the period. Hedge funds and other institutional investors own 79.05% of the company's stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.